home / stock / camrf / camrf short
Short Information | Camurus AB (OTCMKTS:CAMRF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,441 |
Total Actual Volume | 3,745 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 12 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 172 |
Average Short Percentage | 59.68% |
Is there a CAMRF Short Squeeze or Breakout about to happen?
See the CAMRF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-29-2024 | $0 | $46.15 | $0 | $0 | 20 | 20 | 100% |
02-22-2024 | $46.15 | $46.15 | $46.15 | $46.15 | 197 | 197 | 100% |
02-12-2024 | $0 | $50.71 | $0 | $0 | 40 | 40 | 100% |
02-09-2024 | $51.65 | $50.71 | $51.65 | $50.71 | 212 | 112 | 52.83% |
02-05-2024 | $50.68 | $50.68 | $50.68 | $50.68 | 344 | 140 | 40.7% |
11-01-2022 | $0 | $21.81 | $0 | $0 | 150 | 150 | 100% |
07-16-2019 | $8.25 | $8.25 | $8.25 | $8.25 | 100 | 100 | 100% |
11-20-2018 | $9.30 | $9.30 | $9.30 | $9.30 | 475 | 475 | 100% |
11-09-2018 | $10.55 | $10.55 | $10.55 | $10.55 | 379 | 379 | 100% |
08-22-2018 | $10.75 | $10.75 | $10.75 | $10.75 | 200 | 200 | 100% |
07-24-2018 | $10.95 | $10.95 | $10.95 | $10.95 | 1,000 | 1,000 | 100% |
06-20-2018 | $11.45 | $11.45 | $11.45 | $11.45 | 428 | 428 | 100% |
06-11-2018 | $12.5303 | $12.5303 | $12.5303 | $12.5303 | 200 | 200 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Camurus AB Company Name:
CAMRF Stock Symbol:
OTCMKTS Market:
The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence PR Newswire LUND, Sweden , May 3, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) today announced that the Australian regulatory agency, the Therapeutic Good...
Camurus receives positive CHMP opinion for Buvidal 160mg monthly dose for the treatment of opioid dependence PR Newswire LUND, Sweden , March 26, 2021 /PRNewswire/ -- Camurus today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Eu...
Once-weekly formulation of setmelanotide achieved weight loss efficacy comparable to daily-dosing formulation Both weekly and daily formulations of setmelanotide were observed to be safe and well-tolerated LUND, Sweden , June 24, 2020 /PRNewswire/ -- Camurus' partner Rhyt...